Designer DNA therapeutic wipes out cancer stem cells, treats multiple myeloma in mice

by | Jun 15, 2021 | Myeloma News | 0 comments

Source: Multiple Myeloma News — ScienceDaily

A new study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
Read More

Submit a Comment